{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:34:30Z","timestamp":1761975270700},"reference-count":14,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2012,6,20]],"date-time":"2012-06-20T00:00:00Z","timestamp":1340150400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Int J Dermatology"],"published-print":{"date-parts":[[2012,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Stevens\u2013Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are severe and life\u2010threatening adverse drug reactions. Herein we report about a patient with head and neck cancer, who developed SJS\u2010TEN overlap after having received cetuximab and radiotherapy. To date, there are only two reports of TEN associated with cetuximab therapy in patients with cancer. Every skin condition in a patient with cancer leading to extensive exfoliation of the skin should alert the oncologist of a possibility of drug\u2010induced SJS or TEN.<\/jats:p>","DOI":"10.1111\/j.1365-4632.2011.05356.x","type":"journal-article","created":{"date-parts":[[2012,6,21]],"date-time":"2012-06-21T13:29:06Z","timestamp":1340285346000},"page":"864-867","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Stevens\u2013Johnson syndrome and toxic epidermal necrolysis overlap in a patient receiving cetuximab and radiotherapy for head and neck cancer"],"prefix":"10.1111","volume":"51","author":[{"given":"Mirjana","family":"Urosevic\u2010Maiwald","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Harr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars E.","family":"French","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reinhard","family":"Dummer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,6,20]]},"reference":[{"key":"e_1_2_2_2_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2000.00061.x"},{"key":"e_1_2_2_3_2","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-5-39"},{"key":"e_1_2_2_4_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1993.01680220104023"},{"key":"e_1_2_2_5_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.282.5388.490"},{"key":"e_1_2_2_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm.1884"},{"key":"e_1_2_2_7_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1439-0353.2005.04737.x"},{"key":"e_1_2_2_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjoto.2009.02.021"},{"key":"e_1_2_2_9_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.15.7883"},{"key":"e_1_2_2_10_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.136.3.323"},{"key":"e_1_2_2_11_2","volume-title":"Treatment of Skin Disease: Comprehensive Therapeutic Strategies","author":"Craven NM","year":"2009"},{"key":"e_1_2_2_12_2","doi-asserted-by":"crossref","first-page":"206","DOI":"10.2340\/00015555-0249","article-title":"Intravenous immunoglobulin: properties, mode of action and practical use in dermatology","volume":"87","author":"Prins C","year":"2007","journal-title":"Acta Derm Venereol"},{"key":"e_1_2_2_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2007.08.039"},{"key":"e_1_2_2_14_2","first-page":"743","article-title":"High\u2010dose intravenous immunoglobulins in the treatment of Stevens\u2010Johnson syndrome and toxic epidermal necrolysis in Chinese patients: a retrospective study of 82 cases","volume":"20","author":"Chen J","year":"2010","journal-title":"Eur J Dermatol"},{"key":"e_1_2_2_15_2","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1684\/ejd.2008.0580","article-title":"Guidelines on the use of high\u2010dose intravenous immunoglobulin in dermatology","volume":"19","author":"Enk A","year":"2009","journal-title":"Eur J Dermatol"}],"container-title":["International Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-4632.2011.05356.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-4632.2011.05356.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T03:43:48Z","timestamp":1697341428000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-4632.2011.05356.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6,20]]},"references-count":14,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["10.1111\/j.1365-4632.2011.05356.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-4632.2011.05356.x","archive":["Portico"],"relation":{},"ISSN":["0011-9059","1365-4632"],"issn-type":[{"value":"0011-9059","type":"print"},{"value":"1365-4632","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6,20]]},"assertion":[{"value":"2012-06-20","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}